These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37165121)

  • 41. Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes.
    Saratsis AM; Kambhampati M; Snyder K; Yadavilli S; Devaney JM; Harmon B; Hall J; Raabe EH; An P; Weingart M; Rood BR; Magge SN; MacDonald TJ; Packer RJ; Nazarian J
    Acta Neuropathol; 2014; 127(6):881-95. PubMed ID: 24297113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: report from the International DIPG Registry.
    Leach JL; Roebker J; Schafer A; Baugh J; Chaney B; Fuller C; Fouladi M; Lane A; Doughman R; Drissi R; DeWire-Schottmiller M; Ziegler DS; Minturn JE; Hansford JR; Wang SS; Monje-Deisseroth M; Fisher PG; Gottardo NG; Dholaria H; Packer R; Warren K; Leary SES; Goldman S; Bartels U; Hawkins C; Jones BV
    Neuro Oncol; 2020 Nov; 22(11):1647-1657. PubMed ID: 32506137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Context-dependent tumor-suppressive BMP signaling in diffuse intrinsic pontine glioma regulates stemness through epigenetic regulation of CXXC5.
    Sun Y; Yan K; Wang Y; Xu C; Wang D; Zhou W; Guo S; Han Y; Tang L; Shao Y; Shan S; Zhang QC; Tang Y; Zhang L; Xi Q
    Nat Cancer; 2022 Sep; 3(9):1105-1122. PubMed ID: 35915262
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study.
    Fleischhack G; Massimino M; Warmuth-Metz M; Khuhlaeva E; Janssen G; Graf N; Rutkowski S; Beilken A; Schmid I; Biassoni V; Gorelishev SK; Kramm C; Reinhard H; Schlegel PG; Kortmann RD; Reuter D; Bach F; Iznaga-Escobar NE; Bode U
    J Neurooncol; 2019 May; 143(1):107-113. PubMed ID: 30830679
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor dissemination through surgical tracts in diffuse intrinsic pontine glioma.
    Lobon-Iglesias MJ; Santa-Maria Lopez V; Puerta Roldan P; Candela-Cantó S; Ramos-Albiac M; Gomez-Chiari M; Puget S; Bolle S; Goumnerova L; Kieran MW; Cruz O; Grill J; Morales La Madrid A
    J Neurosurg Pediatr; 2018 Dec; 22(6):678-683. PubMed ID: 30192215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pediatric diffuse intrinsic pontine glioma patients from a single center.
    Kebudi R; Cakir FB; Agaoglu FY; Gorgun O; Ayan I; Darendeliler E
    Childs Nerv Syst; 2013 Apr; 29(4):583-8. PubMed ID: 23224361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. T2-FLAIR Mismatch Sign and Response to Radiotherapy in Diffuse Intrinsic Pontine Glioma.
    Yamasaki F; Nishibuchi I; Karakawa S; Kaichi Y; Kolakshyapati M; Takano M; Yonezawa U; Imano N; Taguchi A; Shimomura M; Taniguchi M; Onishi S; Okada S; Awai K; Sugiyama K; Nagata Y
    Pediatr Neurosurg; 2021; 56(1):1-9. PubMed ID: 33535215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of diffuse pontine gliomas in children: recent developments.
    Kebudi R; Cakir FB
    Paediatr Drugs; 2013 Oct; 15(5):351-62. PubMed ID: 23719782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential Expression of Wilms' Tumor Protein in Diffuse Intrinsic Pontine Glioma.
    Lee S; Kambhampati M; Yadavilli S; Gordish-Dressman H; Santi M; Cruz CR; Packer RJ; Almira-Suarez MI; Hwang EI; Nazarian J
    J Neuropathol Exp Neurol; 2019 May; 78(5):380-388. PubMed ID: 30990879
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas.
    Wu G; Broniscer A; McEachron TA; Lu C; Paugh BS; Becksfort J; Qu C; Ding L; Huether R; Parker M; Zhang J; Gajjar A; Dyer MA; Mullighan CG; Gilbertson RJ; Mardis ER; Wilson RK; Downing JR; Ellison DW; Zhang J; Baker SJ;
    Nat Genet; 2012 Jan; 44(3):251-3. PubMed ID: 22286216
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diffuse intrinsic pontine gliomas: Diagnostic approach and treatment strategies.
    Janjua MB; Ban VS; El Ahmadieh TY; Hwang SW; Samdani AF; Price AV; Weprin BE; Batjer H
    J Clin Neurosci; 2020 Feb; 72():15-19. PubMed ID: 31870682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brainstem pilocytic astrocytoma with H3 K27M mutation: case report.
    Morita S; Nitta M; Muragaki Y; Komori T; Masui K; Maruyama T; Ichimura K; Nakano Y; Sawada T; Koriyama S; Tsuzuki S; Yasuda T; Hashimoto K; Niwa A; Kawamata T
    J Neurosurg; 2018 Sep; 129(3):593-597. PubMed ID: 28960151
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemotherapy of Intracranial Gliomas in Children.
    Terashima K
    Prog Neurol Surg; 2018; 31():162-167. PubMed ID: 29393184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology.
    Jansen MH; van Vuurden DG; Vandertop WP; Kaspers GJ
    Cancer Treat Rev; 2012 Feb; 38(1):27-35. PubMed ID: 21764221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Progress in diffuse intrinsic pontine glioma: advocating for stereotactic biopsy in the standard of care.
    Williams JR; Young CC; Vitanza NA; McGrath M; Feroze AH; Browd SR; Hauptman JS
    Neurosurg Focus; 2020 Jan; 48(1):E4. PubMed ID: 31896081
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical trials for diffuse intrinsic pontine glioma: the current state of affairs.
    Rechberger JS; Lu VM; Zhang L; Power EA; Daniels DJ
    Childs Nerv Syst; 2020 Jan; 36(1):39-46. PubMed ID: 31489454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003.
    Kline C; Jain P; Kilburn L; Bonner ER; Gupta N; Crawford JR; Banerjee A; Packer RJ; Villanueva-Meyer J; Luks T; Zhang Y; Kambhampati M; Zhang J; Yadavilli S; Zhang B; Gaonkar KS; Rokita JL; Kraya A; Kuhn J; Liang W; Byron S; Berens M; Molinaro A; Prados M; Resnick A; Waszak SM; Nazarian J; Mueller S
    Clin Cancer Res; 2022 Sep; 28(18):3965-3978. PubMed ID: 35852795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. OLIG2 maintenance is not essential for diffuse intrinsic pontine glioma cell line growth but regulates tumor phenotypes.
    Liao Y; Luo Z; Deng Y; Zhang F; Rao R; Wang J; Xu L; Kumar SS; Sengupta S; DeWire-Schottmiller M; Berry K; Garrett M; Fouladi M; Drissi R; Lu QR
    Neuro Oncol; 2021 Jul; 23(7):1183-1196. PubMed ID: 33539525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic targeting of transcriptional elongation in diffuse intrinsic pontine glioma.
    Katagi H; Takata N; Aoi Y; Zhang Y; Rendleman EJ; Blyth GT; Eckerdt FD; Tomita Y; Sasaki T; Saratsis AM; Kondo A; Goldman S; Becher OJ; Smith E; Zou L; Shilatifard A; Hashizume R
    Neuro Oncol; 2021 Aug; 23(8):1348-1359. PubMed ID: 33471107
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Long Non-Coding RNA H19 Drives the Proliferation of Diffuse Intrinsic Pontine Glioma with H3K27 Mutation.
    Roig-Carles D; Jackson H; Loveson KF; Mackay A; Mather RL; Waters E; Manzo M; Alborelli I; Golding J; Jones C; Fillmore HL; Crea F
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.